118 related articles for article (PubMed ID: 28801299)
21. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
Rahmani M; Nguyen TK; Dent P; Grant S
Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
[TBL] [Abstract][Full Text] [Related]
22. [Establishment of an imatinib resistant cell line K562/G01 and its characterization].
Qi J; Peng H; Gu ZL; Liang ZQ; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):337-41. PubMed ID: 15308010
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism underlying 2-methoxyestradiol inducing apoptosis of K562 cells].
Zhang XY; Zhan R; Huang HB; Yang T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):340-4. PubMed ID: 19379563
[TBL] [Abstract][Full Text] [Related]
24. Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.
Ozkan T; Hekmatshoar Y; Ertan-Bolelli T; Hidayat AN; Beksac M; Aki-Yalcin E; Yalcin I; Sunguroglu A
Anticancer Agents Med Chem; 2018; 18(11):1521-1530. PubMed ID: 29298654
[TBL] [Abstract][Full Text] [Related]
25. [Effect of Stably Down-regulating FMI Expression of K562 Cells on Sensitivity of K562 cells to Imatinib Mesylate].
Han YH; Zhang HX; Hong F; Yu D; Hu CY; Sun Q; Zeng LY; Li ZY; Yan ZL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):708-716. PubMed ID: 31204920
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Steadily Down-regulating VE-Cadherin Expression on Susceptibitity of K562 Cells to Chemotherapy].
Hong F; Zhang HX; Chen C; Yan ZL; Wu QY; Zeng LY; Li ZY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):691-697. PubMed ID: 29950205
[TBL] [Abstract][Full Text] [Related]
27. [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression].
Zhang BZ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1182-5. PubMed ID: 18088462
[TBL] [Abstract][Full Text] [Related]
28. microRNA-199a/b-5p enhance imatinib efficacy via repressing WNT2 signaling-mediated protective autophagy in imatinib-resistant chronic myeloid leukemia cells.
Chen PH; Liu AJ; Ho KH; Chiu YT; Anne Lin ZH; Lee YT; Shih CM; Chen KC
Chem Biol Interact; 2018 Aug; 291():144-151. PubMed ID: 29890129
[TBL] [Abstract][Full Text] [Related]
29. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
30. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
31. [Combined Effect of Bortezomib and Homoharringtonine on K562 Cells and their Mechanisms].
Xie C; Tang AP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):395-400. PubMed ID: 29665904
[TBL] [Abstract][Full Text] [Related]
32. [Triptolide inhibits proliferation and induces apoptosis of imatinib resistant K562/G01 cells].
Wen SQ; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1148-52. PubMed ID: 24156423
[TBL] [Abstract][Full Text] [Related]
33. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
34. The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.
Grimaudo S; Meli M; Di Cristina A; Ferro A; Pipitone MR; Romagnoli R; Simoni D; Dieli F; Tolomeo M
Anticancer Drugs; 2013 Apr; 24(4):384-93. PubMed ID: 23370613
[TBL] [Abstract][Full Text] [Related]
35. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
36. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells].
Liu BC; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035
[TBL] [Abstract][Full Text] [Related]
37. The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL.
Ru Y; Wang Q; Liu X; Zhang M; Zhong D; Ye M; Li Y; Han H; Yao L; Li X
Sci Rep; 2016 Jun; 6():28352. PubMed ID: 27329306
[TBL] [Abstract][Full Text] [Related]
38. Bcr-Abl-independent imatinib-resistant K562 cells show aberrant protein acetylation and increased sensitivity to histone deacetylase inhibitors.
Lee SM; Bae JH; Kim MJ; Lee HS; Lee MK; Chung BS; Kim DW; Kang CD; Kim SH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1084-92. PubMed ID: 17569822
[TBL] [Abstract][Full Text] [Related]
39. MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
Wong SM; Liu FH; Lee YL; Huang HM
PLoS One; 2016; 11(1):e0148093. PubMed ID: 26815740
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells.
Okabe S; Tauchi T; Ohyashiki K
Clin Cancer Res; 2008 Oct; 14(19):6181-6. PubMed ID: 18829496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
